Cargando…
Endogenous Bufadienolides, Fibrosis and Preeclampsia
Frequency of preeclampsia has no tendency to decrease, and it still takes the leading position in the structure of maternal mortality and morbidity worldwide. In this review, we present the “fibrotic concept” of the etiology and pathogenesis of preeclampsia which involves system consisting of Na/K-A...
Autores principales: | Reznik, Vitaliy A., Kashkin, Vladimir A., Agalakova, Natalia I., Adair, C. David, Bagrov, Alexei Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930759/ https://www.ncbi.nlm.nih.gov/pubmed/31915545 http://dx.doi.org/10.1155/2019/5019287 |
Ejemplares similares
-
Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis
por: Agalakova, Natalia I., et al.
Publicado: (2021) -
Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia
por: Fedorova, Olga V., et al.
Publicado: (2018) -
Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia
por: Agalakova, Natalia I., et al.
Publicado: (2022) -
Fli1 and Tissue Fibrosis in Various Diseases
por: Mikhailova, Elena V., et al.
Publicado: (2023) -
Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides
por: Shao, Huili, et al.
Publicado: (2021)